Vibrio type III effector VPA1380 is related to the cysteine protease domain of large bacterial toxins

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Calder, Thomas ^a   Kinch, Lisa N ^a   Fernandez, Jessie ^a   Salomon, Dor ^a   Grishin, Nick V ^a,b   Orth, Kim ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL TOXIN; CYSTEINE PROTEINASE; PHYTIC ACID; UNCLASSIFIED DRUG; VPA1380 PROTEIN; BACTERIAL SECRETION SYSTEM; ENZYME ACTIVATOR; RECOMBINANT PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; BIOINFORMATICS; CATALYSIS; CONTROLLED STUDY; NONHUMAN; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESIDUE ANALYSIS; TYPE III SECRETION SYSTEM; VIBRIO; YEAST CELL; BACTERIAL SECRETION SYSTEM; BIOSYNTHESIS; GENE EXPRESSION; GENETICS; METABOLISM; PATHOGENICITY; PHYSIOLOGY; SACCHAROMYCES CEREVISIAE; VIBRIO PARAHAEMOLYTICUS;

BACTERIAL SECRETION SYSTEMS; BACTERIAL TOXINS; CYSTEINE PROTEASES; ENZYME ACTIVATORS; GENE EXPRESSION; PHYTIC ACID; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; VIBRIO PARAHAEMOLYTICUS;

EID: 84905460194     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104387     Document Type: Article

References (44)

1. Broberg CA, Calder TJ, Orth K (2011) Vibrio parahaemolyticus cell biology and pathogenicity determinants. Microbes Infect 13: 992-1001.
2. Shimohata T, Takahashi A (2010) Diarrhea induced by infection of Vibrio parahaemolyticus. J Med Invest 57: 179-182.
3. Daniels NA, MacKinnon L, Bishop R, Altekruse S, Ray B, et al. (2000) Vibrio parahaemolyticus infections in the United States, 1973-1998. J Infect Dis 181: 1661-1666. (Pubitemid 30387758)
4. Nair GB, Ramamurthy T, Bhattacharya SK, Dutta B, Takeda Y, et al. (2007) Global dissemination of Vibrio parahaemolyticus serotype O3: K6 and its serovariants. Clin Microbiol Rev 20: 39-48. (Pubitemid 46167767)
5. Su YC, Liu C (2007) Vibrio parahaemolyticus : a concern of seafood safety. Food Microbiol 24: 549-558.
6. Makino K, Oshima K, Kurokawa K, Yokoyama K, Uda T, et al. (2003) Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V cholerae. Lancet 361: 743-749. (Pubitemid 36293629)
7. Park KS, Ono T, Rokuda M, Jang MH, Okada K, et al. (2004) Functional characterization of two type III secretion systems of Vibrio parahaemolyticus. Infect Immun 72: 6659-6665. (Pubitemid 39425449)
8. Salomon D, Gonzalez H, Updegraff BL, Orth K (2013) Vibrio parahaemolyticus type VI secretion system 1 is activated in marine conditions to target bacteria, and is differentially regulated from system 2. PLoS One 8: e61086.
9. Gotoh K, Kodama T, Hiyoshi H, Izutsu K, Park KS, et al. (2010) Bile acid-induced virulence gene expression of Vibrio parahaemolyticus reveals a novel therapeutic potential for bile acid sequestrants. PLoS One 5: e13365.
10. Ritchie JM, Rui H, Zhou X, Iida T, Kodoma T, et al. (2012) Inflammation and disintegration of intestinal villi in an experimental model for Vibrio parahaemolyticus-induced diarrhea. PLoS Pathog 8: e1002593.
11. Pineyro P, Zhou X, Orfe LH, Friel PJ, Lahmers K, et al. (2010) Development of two animal models to study the function of Vibrio parahaemolyticus type III secretion systems. Infect Immun 78: 4551-4559.
12. Zhou X, Gewurz BE, Ritchie JM, Takasaki K, Greenfeld H, et al. (2013) A Vibrio parahaemolyticus T3SS effector mediates pathogenesis by independently enabling intestinal colonization and inhibiting TAK1 activation. Cell Rep 3: 1690-1702.
13. Zhang L, Krachler AM, Broberg CA, Li Y, Mirzaei H, et al. (2012) Type III effector VopC mediates invasion for Vibrio species. Cell Rep 1: 453-460.
14. Galan JE, Wolf-Watz H (2006) Protein delivery into eukaryotic cells by type III secretion machines. Nature 444: 567-573. (Pubitemid 44864429)
15. Trosky JE, Mukherjee S, Burdette DL, Roberts M, McCarter L, et al. (2004) Inhibition of MAPK signaling pathways by VopA from Vibrio parahaemolyticus. J Biol Chem 279: 51953-51957. (Pubitemid 39656564)
16. Liverman AD, Cheng HC, Trosky JE, Leung DW, Yarbrough ML, et al. (2007) Arp2/3-independent assembly of actin by Vibrio type III effector VopL. Proc Natl Acad Sci U S A 104: 17117-17122. (Pubitemid 350211001)
17. Hiyoshi H, Kodama T, Saito K, Gotoh K, Matsuda S, et al. (2011) VopV, an F-actin-binding type III secretion effector, is required for Vibrio parahaemolyticus-induced enterotoxicity. Cell Host Microbe 10: 401-409.
18. Okada R, Zhou X, Hiyoshi H, Matsuda S, Chen X, et al. (2013) The Vibrio parahaemolyticus effector VopC mediates Cdc42-dependent invasion of cultured cells but is not required for pathogenicity in an animal model of infection. Cell Microbiol.
19. Zurawski DV, Mumy KL, Faherty CS, McCormick BA, Maurelli AT (2009) Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein. Mol Microbiol 71: 350-368.
20. Fukazawa A, Alonso C, Kurachi K, Gupta S, Lesser CF, et al. (2008) GEF-H1 mediated control of NOD1 dependent NF-kappaB activation by Shigella effectors. PLoS Pathog 4: e1000228.
21. Park KS, Ono T, Rokuda M, Jang MH, Iida T, et al. (2004) Cytotoxicity and enterotoxicity of the thermostable direct hemolysin-deletion mutants of Vibrio parahaemolyticus. Microbiol Immunol 48: 313-318. (Pubitemid 38508672)
22. Salomon D, Bosis E, Dar D, Nachman I, Sessa G (2012) Expression of Pseudomonas syringae type III effectors in yeast under stress conditions reveals that HopX1 attenuates activation of the high osmolarity glycerol MAP kinase pathway. Microbiology 158: 2859-2869.
23. Salomon D, Dar D, Sreeramulu S, Sessa G (2011) Expression of Xanthomonas campestris pv. vesicatoria type III effectors in yeast affects cell growth and viability. Mol Plant Microbe Interact 24: 305-314.
24. Slagowski NL, Kramer RW, Morrison MF, LaBaer J, Lesser CF (2008) A functional genomic yeast screen to identify pathogenic bacterial proteins. PLoS Pathog 4: e9.
25. Lupardus PJ, Shen A, Bogyo M, Garcia KC (2008) Small molecule-induced allosteric activation of the Vibrio cholerae RTX cysteine protease domain. Science 322: 265-268.
26. Pruitt RN, Chagot B, Cover M, Chazin WJ, Spiller B, et al. (2009) Structure-function analysis of inositol hexakisphosphate-induced autoprocessing in Clostridium difficile toxin A. J Biol Chem 284: 21934-21940.
27. Reineke J, Tenzer S, Rupnik M, Koschinski A, Hasselmayer O, et al. (2007) Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446: 415-419. (Pubitemid 46474600)
28. Egerer M, Satchell KJ (2010) Inositol hexakisphosphate-induced autoprocessing of large bacterial protein toxins. PLoS Pathog 6: e1000942.
29. Prochazkova K, Shuvalova LA, Minasov G, Voburka Z, Anderson WF, et al. (2009) Structural and molecular mechanism for autoprocessing of MARTX toxin of Vibrio cholerae at multiple sites. J Biol Chem 284: 26557-26568.
30. York JD, Odom AR, Murphy R, Ives EB, Wente SR (1999) A phospholipase C-dependent inositol polyphosphate kinase pathway required for efficient messenger RNA export. Science 285: 96-100. (Pubitemid 29307573)
31. Prochazkova K, Satchell KJ (2008) Structure-function analysis of inositol hexakisphosphate-induced autoprocessing of the Vibrio cholerae multifunctional autoprocessing RTX toxin. J Biol Chem 283: 23656-23664.
32. Egerer M, Giesemann T, Herrmann C, Aktories K (2009) Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphate. J Biol Chem 284: 3389-3395.
33. Salomon D, Orth K (2013) What pathogens have taught us about posttranslational modifications. Cell Host Microbe 14: 269-279.
34. Juris SJ, Rudolph AE, Huddler D, Orth K, Dixon JE (2000) A distinctive role for the Yersinia protein kinase: actin binding, kinase activation, and cytoskeleton disruption. Proc Natl Acad Sci U S A 97: 9431-9436. (Pubitemid 30650792)
35. Zhou Y, Dong N, Hu L, Shao F (2013) The Shigella type three secretion system effector OspG directly and specifically binds to host ubiquitin for activation. PLoS One 8: e57558.
36. Coaker G, Falick A, Staskawicz B (2005) Activation of a phytopathogenic bacterial effector protein by a eukaryotic cyclophilin. Science 308: 548-550. (Pubitemid 40570584)
37. Coaker G, Zhu G, Ding Z, Van Doren SR, Staskawicz B (2006) Eukaryotic cyclophilin as a molecular switch for effector activation. Mol Microbiol 61: 1485-1496. (Pubitemid 44359377)
38. Buss C, Muller D, Ruter C, Heusipp G, Schmidt MA (2009) Identification and characterization of Ibe, a novel type III effector protein of A/E pathogens targeting human IQGAP1. Cell Microbiol 11: 661-677.
39. Salomon D, Sessa G (2010) Identification of growth inhibition phenotypes induced by expression of bacterial type III effectors in yeast. J Vis Exp.
40. Salomon D, Guo Y, Kinch LN, Grishin NV, Gardner KH, et al. (2013) Effectors of animal and plant pathogens use a common domain to bind host phosphoinositides. Nat Commun 4: 2973.
41. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402. (Pubitemid 27359211)
42. Soding J, Biegert A, Lupas AN (2005) The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res 33: W244-248. (Pubitemid 44529917)
43. Pei J, Grishin NV (2014) PROMALS3D: multiple protein sequence alignment enhanced with evolutionary and three-dimensional structural information. Methods Mol Biol 1079: 263-271.
44. Cole C, Barber JD, Barton GJ (2008) The Jpred 3 secondary structure prediction server. Nucleic Acids Res 36: W197-201.